Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
dna
2
×
23andme
achromatopsia
beta-thalassemia
bill cassidy
bluebird bio
boston blog main
boston top stories
clinical trials
deals
disease
extreme
fda
gene therapy
genetics
harvard pilgrim health care
hemophilia
johnson & johnson
life sciences
luxturna
mark warner
mathai mammen
medicaid
medicine
meiragtx
national blog main
national top stories
new york
new york blog main
new york top stories
novartis
parkinson's disease
patient affordability value and efficiency act
science
spark therapeutics
spinal muscular atrophy
university of pennsylvania
value based agreements
x-linked retinitis pigmentosa
zolgensma
What
j
2
×
age
andme
appeared
awarded
bigger
biggest
come
community.the
data
deal
emerging
extremetech
factors
foundation
fox
gather
gave
gene
genetic
grant
johnson
medical
meiragtx
michael
million
morning
parkinson’s
past
post
shared
signal
signals
study
therapy
years
Language
Current search:
j
×
dna
×
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@extremetech.com
6 years ago
23andMe, Michael J. Fox Foundation to Study Genetic Factors of Parkinson’s
